Stock Fundamentals

Company Information

Company Name
Palvella Therapeutics, Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US6979471090
CIK: 0001742961
Currency: USD
Full Time Employees: 14
Phone: 484 253 1461
Fiscal Year End: December
IPO Date: Dec 16, 2024
Description:

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania

Address:

125 Strafford Avenue, Wayne, PA, United States, 19087

Directors & Officers

Name Title Year Born
Mr. Wesley H. Kaupinen Founder, President, CEO & Director NA
Ms. Kathleen Goin Chief Operating Officer 1971
Dr. Jeffrey Martini Ph.D. Chief Scientific Officer 1978
Mr. Matthew E. Korenberg CFO & Treasurer 1975
Ms. Bohan Wei Vice President of Corporate Development & New Product Planning NA
Ms. Emily Cook Senior Vice President of Clinical Operations NA
Mr. Jason Burdette SVP of CMC & Technical Operations NA
Ms. Ashley Kline Chief Commercial Officer NA
Dr. David W. Osborne Ph.D. Chief Innovation Officer 1961
Dr. Vimal Patel Pharm.D. Senior VP of Medical Affairs NA

Shares Statistics

Shares Outstanding: 11.84M
Shares Float: 6.80M
% Insiders: 2,135.70%
% Institutions: 8,640.40%
Short % Float: 16.99%

Valuation Metrics

Enterprise Value: $1.53B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.60B
Book Value: $3.49
Earnings/Share: $-2.92
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -47.54%
ROE (TTM): -301.19%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 7.33x 0.00x 0.29x -3.26x 0.00x
2023-12-31 3.20x 0.00x 1.51x N/A 0.00x
2022-12-31 2.86x -0.04x 2.40x N/A -0.03x
2021-12-31 2.52x 0.02x 0.67x N/A -0.02x
2020-12-31 3.42x 0.03x 0.70x N/A -0.03x
2019-12-31 N/A N/A N/A N/A 0.00x
2018-12-31 N/A N/A N/A N/A 0.00x
2017-12-31 N/A N/A N/A N/A 0.00x
2016-12-31 N/A N/A N/A N/A 0.00x
2015-12-31 N/A N/A N/A N/A 0.00x
2014-12-31 N/A N/A N/A -2.71x 0.00x
2013-12-31 N/A N/A N/A 1.12x 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 21, 2026 Kathleen Goin N/A Sale 4.30K $97.63 $420.00K
Dec 17, 2025 Kathleen Goin N/A Sale 4.30K $96.47 $415.01K
Nov 19, 2025 Kathleen Goin N/A Sale 4.30K $86.23 $370.96K
Apr 09, 2025 George M Jenkins N/A Purchase 2.50K $20.13 $50.33K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PVLA.US!